The substantial overlap between TN-associated markers identified here, and those found by other studies on invasive breast cancer (including MLPH, CA12, FOXA1, SPDEF, FOXC1), suggest there is a clear distinction of this subtype even at the pre-invasive stage17–19. This evidence concerns the gene FOXA1 and invasive breast carcinoma.